-
Morgan Stanley: Health Care M&A Means Headwinds For Hospitals
Wednesday, December 20, 2017 - 2:55pm | 516Hospital stocks are in line to profit off potential tax reform, but that might be where the good news ends. Morgan Stanley expects a potentially radical shift in health care services toward payer vertical integration to shake the industry and strain traditional competitors. The Rating Analyst...
-
Portfolio Manager Says Now Is A Great Time To Buy Biotech
Wednesday, November 15, 2017 - 3:13pm | 455Shares of one of the most tracked biotech exchange traded fund, iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) dipped below its 200-day moving average on Tuesday for the first time in months. The ETF is also more than 10 percent removed from its 52-week highs, which has some investors...
-
Envision Q4 Outlook Disappoints, But All Hope Is Not Lost
Wednesday, November 1, 2017 - 11:01am | 350Investors tend to lose confidence in a company's outlook after a stock plunges 30 percent in one day, but that shouldn't be the case when it comes to Envision Healthcare Corporation (NYSE: EVHC), at least according to analysts at Canaccord Genuity. The firm's Richard Close maintains a Buy rating on...
-
Envision Healthcare Fundamentals Are 'Questionable,' Expect A Sell-Off
Wednesday, November 1, 2017 - 9:54am | 683Shares of Envision Healthcare Corporation (NYSE: EVHC) were trading notably lower by more than 30 percent Wednesday morning in reaction to the company's disappointing earnings report. Envision Healthcare cited the impact of hurricanes Harvey and Irma for its poor performance in the quarter, but...
-
Buy Thermo Fisher On Amazon Fear-Inspired Dip
Monday, October 30, 2017 - 1:28pm | 489Shares of Thermo Fisher Scientific Inc. (NYSE: TMO) came under heavy selling pressure last Friday, which continued into Monday's trading session amid ongoing concerns that Amazon.com, Inc. (NASDAQ: AMZN) is looking to enter lab supplies and other health care related businesses. But Thermo Fisher's...
-
Analyst: Don't Buy The Weakness In Acadia Healthcare
Monday, October 30, 2017 - 10:45am | 384Investors looking to buy shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) after a 25-percent decline in reaction to a disappointing earnings report may want to reconsider, according to analysts at Mizuho Securities. The firm's Ann Hynes downgraded Acadia's stock rating from Buy to Neutral...
-
Oppenheimer Presents New Menu Of Top Picks
Friday, September 1, 2017 - 10:59am | 1280If you’re looking for a financial feast, check Oppenheimer’s choice platter. The firm’s 28 research analysts updated their monthly list of top picks this week, with just more than half of the catalog intact from the start of the summer. Here is what comes highly recommended:...
-
Doctor Says Health Care ETFs Look Healthy
Thursday, August 17, 2017 - 7:29am | 505Health care, the S&P 500's third-largest sector allocation, is rebounding nicely after slumping in 2016 when the sector notched its first negative showing on an annual basis. This year, the Health Care Select Sector SPDR (NYSE: XLV) is higher by nearly 15 percent. Although the health care...
-
5 Mutual Funds Basking In Optimism Over Healthcare Bill
Thursday, June 29, 2017 - 3:53pm | 1355Senate Republicans recently introduced a draft Bill to replace Obamacare to remove the obstacles in the way of Medicaid expansion. This Bill adds to the positive sentiments over President Trump's much-awaited pro-growth policies like tax reforms, which are expected to benefit biotech companies...
-
Warren Buffett Talks Taxes, Health Care Reform: This Is The 'Relief For The Rich Act'
Thursday, June 29, 2017 - 2:27pm | 775Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) CEO Warren Buffett appeared on PBS NewsHour this week, where he spoke on, among other things, tax and health care reform. Single-Payer Health Care Is The ‘Best System’ During his interview, Buffett criticized the belief in government...
-
Blackstone's Vice Chairman Explains President Trump's Best Attribute
Monday, April 3, 2017 - 1:23pm | 415President Donald Trump is still dealing with a major blow to his presidency as his campaign promise of repealing and replacing the Affordable Care Act failed to even make it to a vote. But according to Blackstone's John Studzinski, the president is in good position to rebound from his defeat....
-
Blackstone's Vice Chairman Explains Why The Market Is Due For A Correction
Wednesday, March 22, 2017 - 12:21pm | 371Byron Wien, Blackstone's multi-asset investment group vice chairman, was a guest on CNBC and explained why he felt the stock market is due for a correction. Wien pointed out that the stock market has seen gains nearly every single day since the 2016 election under the assumption that President...
-
Pfizer Reports Better-Than-Expected Q4, Shares Dip Lower
Tuesday, February 2, 2016 - 7:23am | 229Shares of Pfizer Inc. (NYSE: PFE) were trading lower by around 0.5 percent early Tuesday morning after the company reported its fourth quarter results. Pfizer earned $0.53 per share in the fourth quarter on revenue of $14.05 billion. Wall Street analysts were expecting the company to earn $0.52...
-
NeuroMetrix Announces FDA Clearance For Upgraded Version Of Quell, Shares Surge
Wednesday, January 6, 2016 - 1:22pm | 199Shares of Neurometrix Inc (NASDAQ: NURO), a healthcare company that develops wearable medical technology, announced during CES 2016 it received clearance from the U.S. Food and Drug Administration for an upgraded version of Quell, a chronic pain relief wearable. Neurometrix also confirmed the...
-
15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference
Tuesday, December 1, 2015 - 4:45pm | 553Piper Jaffray is hosting its 27th Annual Health Care Conference December 1-2 in New York. Public biotechnology, specialty pharmaceuticals, drug discovery, medical technology, and other health care services companies will take part in the event. The conference addresses important questions in...